Search Results

There are 4868 results for: content related to: Self-administered, subcutaneous alemtuzumab to treat residual disease in patients with chronic lymphocytic leukemia

  1. Alemtuzumab for patients with chronic lymphocytic leukaemia

    Intervention Review

    The Cochrane Library

    Nicole Skoetz, Kathrin Bauer, Thomas Elter, Ina Monsef, Verena Roloff, Michael Hallek and Andreas Engert

    Published Online : 15 FEB 2012, DOI: 10.1002/14651858.CD008078.pub2

  2. Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab

    Pediatric Blood & Cancer

    Volume 60, Issue 1, January 2013, Pages: 101–109, Rebecca A. Marsh, Carl E. Allen, Kenneth L. McClain, Joanna L. Weinstein, Julie Kanter, Jodi Skiles, Nadine D. Lee, Shakila P. Khan, Julia Lawrence, Jun Q. Mo, Jack J. Bleesing, Alexandra H. Filipovich and Michael B. Jordan

    Version of Record online : 22 APR 2012, DOI: 10.1002/pbc.24188

  3. You have free access to this content
    Alemtuzumab for multiple sclerosis

    Intervention Review

    The Cochrane Library

    Rachel Riera, Gustavo JM Porfírio and Maria R Torloni

    Published Online : 15 APR 2016, DOI: 10.1002/14651858.CD011203.pub2

  4. The successful use of alemtuzumab for treatment of steroid-refractory acute graft-versus-host disease in pediatric patients

    Pediatric Transplantation

    Volume 18, Issue 1, February 2014, Pages: 94–102, Pooja Khandelwal, Julia Lawrence, Alexandra H. Filipovich, Stella M. Davies, Jacob J. Bleesing, Michael B. Jordan, Parinda Mehta, Sonata Jodele, Michael S. Grimley, Ashish Kumar, Kasiani Myers and Rebecca A. Marsh

    Version of Record online : 30 OCT 2013, DOI: 10.1111/petr.12183

  5. Comparison of alemtuzumab vs. antithymocyte globulin induction therapy in primary non-sensitized renal transplant patients treated with rapid steroid withdrawal

    Clinical Transplantation

    Volume 29, Issue 7, July 2015, Pages: 573–580, Harrison E. Saull, Cher Y. Enderby, Thomas A. Gonwa and Hani M. Wadei

    Version of Record online : 24 MAR 2015, DOI: 10.1111/ctr.12532

  6. You have free access to this content
    Investigation of Lymphocyte Depletion and Repopulation Using Alemtuzumab (Campath-1H) in Cynomolgus Monkeys

    American Journal of Transplantation

    Volume 10, Issue 4, April 2010, Pages: 773–783, D. J. Van Der Windt, C. Smetanka, C. Macedo, J. He, R. Lakomy, R. Bottino, B. Ekser, G. J. Echeverri, D. Metes, J. N. M. Ijzermans, M. Trucco, D. K. C. Cooper and F. G. Lakkis

    Version of Record online : 20 MAR 2010, DOI: 10.1111/j.1600-6143.2010.03050.x

  7. You have free access to this content
    Alemtuzumab in the Treatment of Refractory Acute Rejection and Bronchiolitis Obliterans Syndrome After Human Lung Transplantation

    American Journal of Transplantation

    Volume 7, Issue 12, December 2007, Pages: 2802–2808, B. D. Reams, L. W. Musselwhite, D. W. Zaas, M. P. Steele, S. Garantziotis, P. C. Eu, L. D. Snyder, J. Curl, S. S. Lin, R. D. Davis and S. M. Palmer

    Version of Record online : 30 OCT 2007, DOI: 10.1111/j.1600-6143.2007.02000.x

  8. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients

    Intervention Review

    The Cochrane Library

    Penny Hill, Nicholas B Cross, A Nicholas R Barnett, Suetonia C Palmer and Angela C Webster

    Published Online : 11 JAN 2017, DOI: 10.1002/14651858.CD004759.pub2

  9. You have free access to this content
    Impact of alemtuzumab treatment on the survival and function of human regulatory T cells in vitro


    Volume 141, Issue 1, January 2014, Pages: 123–131, Evis Havari, Michael J. Turner, Juanita Campos-Rivera, Srinivas Shankara, Tri-Hung Nguyen, Bruce Roberts, William Siders and Johanne M. Kaplan

    Version of Record online : 10 DEC 2013, DOI: 10.1111/imm.12178

  10. Infectious complications associated with alemtuzumab use for allogeneic hematopoietic stem cell transplantation: comparison with anti-thymocyte globulin

    Transplant Infectious Disease

    Volume 11, Issue 5, October 2009, Pages: 413–423, S.H. Park, S.-M. Choi, D.-G. Lee, J.-H. Choi, J.-H. Yoo, S.-H. Kim, H.-J. Kim, S.-G. Cho, K.-S. Eom, J.-W. Lee, W.-S. Min, W.-S. Shin and C.-C. Kim

    Version of Record online : 24 AUG 2009, DOI: 10.1111/j.1399-3062.2009.00414.x

  11. You have free access to this content
    Rediscovering alemtuzumab: current and emerging therapeutic roles

    British Journal of Haematology

    Volume 144, Issue 6, March 2009, Pages: 818–831, John G. Gribben and Michael Hallek

    Version of Record online : 12 JAN 2009, DOI: 10.1111/j.1365-2141.2008.07557.x

  12. You have free access to this content
    Ex Vivo-Expanded Cynomolgus Macaque Regulatory T Cells Are Resistant to Alemtuzumab-Mediated Cytotoxicity

    American Journal of Transplantation

    Volume 13, Issue 8, August 2013, Pages: 2169–2178, E. M. Dons, G. Raimondi, H. Zhang, A. F. Zahorchak, J. K. Bhama, L. Lu, M. Ezzelarab, J. N. M. Ijzermans, D. K. C. Cooper and A. W. Thomson

    Version of Record online : 1 MAY 2013, DOI: 10.1111/ajt.12248

  13. You have full text access to this OnlineOpen article
    A comparative study of reduced dose alemtuzumab in matched unrelated donor and related donor reduced intensity transplants

    British Journal of Haematology

    Volume 168, Issue 6, March 2015, Pages: 874–881, Laura Jardine, Amy Publicover, Venetia Bigley, Geoff Hale, Kim Pearce, Anne Dickinson, Graham Jackson and Matthew Collin

    Version of Record online : 29 JAN 2015, DOI: 10.1111/bjh.13239

  14. You have free access to this content
    Alemtuzumab as compared to alternative contemporary induction regimens

    Transplant International

    Volume 25, Issue 5, May 2012, Pages: 518–526, John C. LaMattina, Joshua D. Mezrich, R. Michael Hofmann, David P. Foley, Anthony M. D’Alessandro, Hans W. Sollinger and John D. Pirsch

    Version of Record online : 6 MAR 2012, DOI: 10.1111/j.1432-2277.2012.01448.x

  15. You have free access to this content
    Living Donor Renal Transplantation Using Alemtuzumab Induction and Tacrolimus Monotherapy

    American Journal of Transplantation

    Volume 6, Issue 10, October 2006, Pages: 2409–2417, H. P. Tan, D. J. Kaczorowski, A. Basu, M. Unruh, J. McCauley, C. Wu, J. Donaldson, I. Dvorchik, L. Kayler, A. Marcos, P. Randhawa, C. Smetanka, T. E. Starzl and R. Shapiro

    Version of Record online : 4 AUG 2006, DOI: 10.1111/j.1600-6143.2006.01495.x

  16. You have free access to this content
    Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia


    Volume 119, Issue 12, 15 June 2013, Pages: 2258–2267, Georg Hopfinger, Raymonde Busch, Natali Pflug, Nicole Weit, Anne Westermann, Anna-Maria Fink, Paula Cramer, Nina Reinart, Dirk Winkler, Günter Fingerle-Rowson, Stephan Stilgenbauer, Hartmut Döhner, Gabriele Kandler, Barbara Eichhorst, Michael Hallek and Marco Herling

    Version of Record online : 19 MAR 2013, DOI: 10.1002/cncr.27972

  17. You have free access to this content
    Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma


    Volume 112, Issue 6, 15 March 2008, Pages: 1288–1295, John D. Hainsworth, Elizabeth R. Vazquez, David R. Spigel, Eric Raefsky, James D. Bearden, Ruben A. Saez and F. Anthony Greco

    Version of Record online : 11 JAN 2008, DOI: 10.1002/cncr.23271

  18. A randomized trial of alemtuzumab vs. anti-thymocyte globulin induction in renal and pancreas transplantation

    Clinical Transplantation

    Volume 22, Issue 1, January/February 2008, Pages: 41–49, Alan Farney, Aimee Sundberg, Phillip Moore, Erica Hartmann, Jeff Rogers, William Doares, Anne Jarrett, Patricia Adams and Robert Stratta

    Version of Record online : 23 JUL 2007, DOI: 10.1111/j.1399-0012.2007.00742.x

  19. Delayed allograft inflammation following alemtuzumab induction for kidney transplantation

    Clinical Transplantation

    Volume 27, Issue 5, September/October 2013, Pages: 772–780, Raymond L. Heilman, Hasan A. Khamash, Maxwell L. Smith, Harini A. Chakkera, Adyr A. Moss and Kunam S. Reddy

    Version of Record online : 8 AUG 2013, DOI: 10.1111/ctr.12201

  20. You have free access to this content
    Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemia


    Volume 98, Issue 12, 15 December 2003, Pages: 2657–2663, Susan M. O'Brien, Hagop M. Kantarjian, Deborah A. Thomas, Jorge Cortes, Francis J. Giles, William G. Wierda, Charles A. Koller, Alessandra Ferrajoli, Mary Browning, Susan Lerner, Maher Albitar and Michael J. Keating

    Version of Record online : 6 NOV 2003, DOI: 10.1002/cncr.11871